Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 1997 Nov;14(10):581–588. doi: 10.1023/A:1022528617732

Reduced In Vitro Fertilization of Human Oocytes Correlates with Raised Circulating FSH Levels During Ovarian Stimulation in Normogonadotropic Women Downregulated with GnRH-Analogues

Claus Yding Andersen 1, Lars G Westergaard 2, Anne Grete Byskov 1, Karin Erb 2
PMCID: PMC3454735  PMID: 9447458

Abstract

Purpose: The possible effects of circulating FSH levels as used during IVF treatment on oocyte maturation and subsequent preembryo development were evaluated.

Methods: Serum levels of FSH and LH on days 1 and 8 of ovarian stimulation and on the day of oocyte retrieval (OR) were correlated with subsequent preembryo development in vitro. After pituitary downregulation, 244 normogonadotropic women followed a fixed protocol for the first 7 days of stimulation.

Results: The average FSH concentration on day 8 of stimulation was 11.5 IU/L and exceeded the expected midcycle surge of FSH by more than 25%. In contrast, levels of LH were below an average of 2 IU/L throughout the stimulation period. The concentration of FSH on day 8 and on the day of OR showed a significant inverse correlation with cleavage rate, whereas levels of LH, age, and body mass index showed no such correlation.

Conclusions: Supraphysiologic levels of FSH seems to affect oocyte maturation negatively. Premature resumption of meiosis, leading to retrieval of postmature oocytes with a reduced developmental potential, is suggested as the underlying mechanism.

Keywords: ovarian stimulation, follicle stimulating hormone levels, preembryo development, in vitro fertilization, fertilization

Full Text

The Full Text of this article is available as a PDF (702.4 KB).

REFERENCES

  • 1.Chappel SC, Howles C. Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod. 1991;6:1206–1212. doi: 10.1093/oxfordjournals.humrep.a137513. [DOI] [PubMed] [Google Scholar]
  • 2.Howles CM, Macnamee MC, Edwards RG, Goswamy R, Steptoe PC. Effect of high tonic levels of luteinizing hormone on outcome of in vitro fertilisation. Lancet. 1986;2:521–522. doi: 10.1016/s0140-6736(86)90395-8. [DOI] [PubMed] [Google Scholar]
  • 3.Howles CM, Macnamee MC, Edwards RG. Follicular development and early luteal function of conception and nonconception cycles after human in-vitro fertilization: Endocrine correlates. Hum Reprod. 1987;2:17. doi: 10.1093/oxfordjournals.humrep.a136482. [DOI] [PubMed] [Google Scholar]
  • 4.Macnamee MC, Howles CM, Edwards RG. Pregnancies after IVF when high tonic LH is reduced by long-term treament with GnRH agonists. Hum Reprod. 1987;2:569–571. doi: 10.1093/oxfordjournals.humrep.a136590. [DOI] [PubMed] [Google Scholar]
  • 5.Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinizing hormone, infertility, and miscarriage. Lancet. 1990;336:1141–1144. doi: 10.1016/0140-6736(90)92765-a. [DOI] [PubMed] [Google Scholar]
  • 6.Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 pateints. Clin Endocrinol. 1989;30:459–470. doi: 10.1111/j.1365-2265.1989.tb00446.x. [DOI] [PubMed] [Google Scholar]
  • 7.Shoham Z, Jacobs HS, Insler V. Luteinizing hormone: Its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril. 1993;59:1153–1161. doi: 10.1016/s0015-0282(16)55968-8. [DOI] [PubMed] [Google Scholar]
  • 8.McNatty KP, Smith DM, Makris A, Osathanondh R, Ryan KJ: The microenvironment of the human antral follicle: Interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab. 1979;49:851–860. doi: 10.1210/jcem-49-6-851. [DOI] [PubMed] [Google Scholar]
  • 9.Yding Andersen C. Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab. 1993;77:1227–1234. doi: 10.1210/jcem.77.5.7521343. [DOI] [PubMed] [Google Scholar]
  • 10.Westergaard LG, Erb K, Laursen S, Rex S, Rasmussen P. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Hum Reprod. 1996;11:1209–1213. doi: 10.1093/oxfordjournals.humrep.a019357. [DOI] [PubMed] [Google Scholar]
  • 11.Ben-Rafael Z, Strauss JF, Mastroianni L, Flickinger GL: Differences in ovarian stimulation in human menopausal gonadotropin treated women may be related to follicle-stimulating hormone accumulation. Fertil Steril. 1986;46:586–592. doi: 10.1016/s0015-0282(16)49632-9. [DOI] [PubMed] [Google Scholar]
  • 12.Howles CM, Loumaye E, Giroud D, Luyet G. Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: A multicentre European phase III study. Hum Reprod. 1994;9:424–430. doi: 10.1093/oxfordjournals.humrep.a138522. [DOI] [PubMed] [Google Scholar]
  • 13.Ubaldi F, Camus M, Smitz J, Bennink HC, Van Steirteghem A, Devroey P. Premature luteinization in in vitro fertilization using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril. 1996;66:275–280. doi: 10.1016/s0015-0282(16)58453-2. [DOI] [PubMed] [Google Scholar]
  • 14.Yding Andersen C. Regulation of ovarian androgen production: a key parameter to succes during ovarian stimulation? Hum Reprod. 1995;10:2227–2233. doi: 10.1093/oxfordjournals.humrep.a136274. [DOI] [PubMed] [Google Scholar]
  • 15.Ross GT, Cargille CM, Lipsett MB, Rayford PL, Marshall JR, Strott CA. Pituitary and gonadal hormones during spontaneous and induced menstrual cycles. Recent Prog Horm Res. 1970;26:1–62. doi: 10.1016/b978-0-12-571126-5.50005-4. [DOI] [PubMed] [Google Scholar]
  • 16.Dekel N, Ayolon D, Lewysohn O, Nemo N, Kaplan-Kraices R, Shalgi R. Experimental extension of the time interval between oocyte maturation and ovulation: Effect on fertilization and first cleavage. Fertil Steril. 1995;64:1023–1028. doi: 10.1016/s0015-0282(16)57922-9. [DOI] [PubMed] [Google Scholar]
  • 17.Peluso A. Role of the amplitude of the goandotropin surge in the rat. Fertil Steril. 1990;53:150–154. [PubMed] [Google Scholar]
  • 18.Mattheij JAM, Swarts JJM, van der Heijden AJH, van Helvoort ALB, Kusters IC. Advancement of meiotic resumption in graafian follicles reduces fertility in the rat. Gynecol Obstet Invest. 1993;36:129–135. doi: 10.1159/000292611. [DOI] [PubMed] [Google Scholar]
  • 19.Byskov AG, Yding Andersen C, Hossaini A, Guoliang X: Cumulus cells of oocyte-cumulus complexes secrete a meiosis activating substance when stimulated with FSH. Mol Reprod Dev. 1997;46:296–305. doi: 10.1002/(SICI)1098-2795(199703)46:3<296::AID-MRD8>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  • 20.Lawrence TS, Dekel N, Beers WH. Binding of human chorionic gonadotropin by rat cumuli oophori and granulosa cells: A comparative study. Endocrinology. 1980;106:1114–1118. doi: 10.1210/endo-106-4-1114. [DOI] [PubMed] [Google Scholar]
  • 21.Oxberry BA, Greenwald GS. An autoradiographic study of the binding of 125 I-labelled follicle stimulating hormone, human chorion gonadotropin and prolactin to the hamster ovary throughout the astrous cycle. Biol Reprod. 1982;27:505–516. doi: 10.1095/biolreprod27.2.505. [DOI] [PubMed] [Google Scholar]
  • 22.Lambert A, Rodgers M, Mitchell R, Wood AM, Wardle C, Hilton B, Robertson WR. In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP. Hum Reprod. 1995;10:1928–1935. doi: 10.1093/oxfordjournals.humrep.a136208. [DOI] [PubMed] [Google Scholar]
  • 23.Robertson WR: Gonadotrophin isoform pattern in different pharmaceutical preparations. In Gonadotrophin Isoforms; Facts and Future, J Kahn (ed). Serono Fertility Series Vol 2, 1997, pp 53–61
  • 24.Chappel SC. Heterogeneity of follicle stimulating hormone: Control and physiological function. Hum Reprod Update. 1995;1:479–487. doi: 10.1093/humupd/1.5.479. [DOI] [PubMed] [Google Scholar]
  • 25.Kiddy DS, Sharp PS, White DM. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases. Clin Endocrinol. 1990;32:213–220. doi: 10.1111/j.1365-2265.1990.tb00857.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES